MK-4464
N/A
Report date: 2024/12/13 16:16:22
Base Information
Drug NameMK-4464
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme LLC
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A